orodar tablets sulfadoxine 500 mg and pyrimethamine 25 mg
elys chemical industries limited, kenya - pyrimethamine , sulfadoxine - tablets - sulfadoxine 500 mg and pyrimethamine 25 mg
sulfadoxine + pyrimethamine tablet
edcl (dhaka) - pyrimethamine + sulfadoxine - tablet - 25 mg + 500 mg
pyrimethamine + sulfadoxine tablets 25/500
medopharm, india - pyrimethamine , sulfadoxine - tablets - 25/500
spaq-co® disp 250mg/12.5mg /76.5mg dispersible tablet
shanghai fosun pharmaceutical industrial room 350, no. 25 kangshi road, kangqiao town, - sulfadoxine, pyrimethamine, amodiaquine - dispersible tablet - 250 mg sulfadoxine , 12.5 mg pyrimethamine and - pyrimethamine combinations
wimal plus adult dispersible tablet
universal corporation limited club road, plot no. 13777, p.o box 1748 - 00902, - sulfadoxine, pyrimethamine and amodiaquine - dispersible tablet - each tablet of sulfadoxine/pyrimethamine contains - amodiaquine
wimal plus junior dispersible tablet
universal corporation limited club road, plot no. 13777, p.o box 1748 - 00902, - sulfadoxine, pyrimethamine and amodiaquine - dispersible tablet - each tablet of sulfadoxine/pyrimethamine contains - amodiaquine
pyrimethamine tablet
alvogen inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.
pyrimethamine tablet
fera pharmaceuticals, llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.
pyrimethamine tablet
teva pharmaceuticals, inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis : pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.
pyrimethamine tablet
aurobindo pharma limited - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.